About the Journal

Focus and Scope

Acta Radiológica Portuguesa (ARP) is a double-blind peer-reviewed open access journal that publishes scientific contributions related to the basic and clinical aspects of modern radiology, including diagnostic imaging and interventional techniques, nuclear medicine, radiobiology and radiological physics. It is aimed at the entire clinical and scientific community with an interest in Radiology, but with greater emphasis on its clinical application.

Submitted articles must be original and cannot have been previously published. The accuracy of both contents, as well as the opinions expressed, are the sole responsibility of the authors.

Articles published in ARP may be reproduced in a non-commercial context in accordance with CC BY-NC standards, maintaining credit to the authors and link to the publication through DOI. After publication in ARP, authors can publish articles in public or institutional repositories, always mentioning the previous publication in ARP.

 

History of the Journal

Acta Radiológica Portuguesa (ARP) was founded in 1989 as an official organ of the Portuguese Society of Radiology and Nuclear Medicine (SPRMN). It is a quarterly journal with peer review, with recognized value in the national scientific panorama.

 

Peer Review Process

ARP follows a rigorous double-blind peer review process.

All manuscripts undergo evaluation by the editor-in-chief who may reject them, at this stage, without seeking the opinion of reviewers.

Manuscripts that do not comply with the journal's standards cannot be considered for publication.

Final acceptance is the responsibility of the scientific editor.

In the evaluation, articles may be:

1. a) Accepted without changes
2. b) Accepted after modifications proposed by reviewers
3. c) Rejected

Upon receipt of the manuscript, the editor-in-chief or section editor sends it to at least two reviewers.

Within a maximum period of four weeks, the reviewer must respond to the editor-in-chief indicating his comments regarding the manuscript subject to review, and his suggestion regarding the acceptance, revision or rejection of the work. Within 10 days, the Editorial Board will make a decision, which may be: accept the article without modifications; sending comments from reviewers so that authors can proceed as indicated; rejection. If there are contradictory recommendations from two reviewers, the Editorial decision will be the responsibility of the Section Editor or Editor in Chief, and in some cases the opinion of a third reviewer may be requested.

When changes are proposed, the Authors have 15 days (a period that can be extended at the request of the authors) to submit the new revised version of the manuscript, taking into account the comments of the referees and the editorial board. They must answer all questions asked and submit a revised version of the article, with the changes made highlighted in a different color.

The Editor-in-Chief has 10 days to make a decision about the new version: reject or accept the new version, or submit it to a new assessment by one or more reviewers.

In case of acceptance, at any of the previous stages, it will be communicated to the Corresponding Author.

During the review phase of typographical proofs by the authors, fundamental changes to the articles will not be accepted. The inclusion of these changes may lead to subsequent rejection of the article by decision of the Editor-in-Chief.

In all cases, the reviewers' opinions will be fully communicated to the authors within 6 to 8 weeks from the date of receipt of the manuscript.

 

Editorial Freedom

It is the responsibility of the SPRMN to appoint and remove editors, and to establish a contract with the editors, at the time of their appointment, in which their rights and duties, authority, the general terms of the appointment and the mechanisms for conflict resolution. Publisher performance is assessed using mutually agreed indicators.

The ARP adopts the ICMJE definition of editorial freedom outlined by the World Association of Medical Editors, which states that the editor-in-chief assumes complete authority over the editorial content of the journal as a whole and the publication of its content. SPRMN, as owner of ARP, does not interfere in the process of evaluation, selection, programming or editing of any manuscript, either directly or by maintaining an environment that can strongly influence decisions. The editor bases editorial decisions on the validity of the work and its importance to ARP readers, rather than on the commercial implications they may have for the journal, and is free to express critical but responsible views on all aspects of medicine without fear of reprisals.

 

Exclusivity

ARP does not consider material that has already been published (except abstracts presented at conferences) or that is awaiting publication.

 

Responsibility and Ethics

Informed Consent and Ethical Standards

Authors must ensure that the study that gave rise to the article they submit for publication complies with ethical and legal principles, both in the course of research and in publication, namely with the recommendations of the World Medical Association Declaration of Helsinki, revised in October 2013 and available at http://www.wma.net/en/20activities/10ethics/10helsinki/, and the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals. – Prepared by the International Committee of Medical Journals – ICMJE, revised in 2014, available at http://www.icmje.org/recommendations and the Committee on Publication Ethics (COPE) (http://publicationethics.org/resources/guidelines) . When a work submitted to the ARP describes experiments carried out on humans, it must be specified that the nature, objectives and procedures of the study were fully explained to the participants and that their consent was obtained. This information must appear in the text of the article. Any suspected misconduct will be investigated and reported. Submitted manuscripts must comply with the requirements for submission of manuscripts to biomedical journals. The Journal's editorial policy incorporates into the review and publication process the Editorial Policy Statements recommendations issued by the Council of Science Editors (http ://www.councilscienceeditors.org/i4a/pages/index.cfm?pageid= 3331).

 

Conflict of interest

Authors must declare potential conflicts of interest in the copyright statement. In this context, authors are obliged to disclose any financial and personal relationships that exist in relation to the work that is submitted. They must also identify any benefits that may be associated with the publication of the article, including: shares or financial interests in companies or other institutions, salaries or prizes, scholarships or other forms of financing, consultancies, patent rights or any other types of relationships financial. Any other personal, professional, political, religious, or any other type of relationship that readers may consider likely to influence the article being published must also be reported. This information will be kept confidential during the review of the manuscript and will not influence the editorial decision but will be published with the article if it is accepted. The existence of conflicts of interest for the publication of an article does not constitute a reason for its rejection, as long as such conflicts of interest are duly declared. If in doubt about what constitutes a relevant financial or personal interest, authors should contact the editor-in-chief.

As mentioned in the ICMJE Requirements, authorship requires a substantial contribution to the manuscript, and it is necessary to specify, in a cover letter, each author's contribution to the work. 

 

Authors are those who:

1) Have substantial, direct intellectual contribution to the design and preparation of the article;

2) Participate in the analysis and interpretation of data;

3) Participate in writing the manuscript, reviewing versions and critically reviewing the content; approval of the final version;

4) Agree that they are responsible for the accuracy and integrity of all work. In addition to being responsible for the parts of the work they did, an author must be able to identify which of the co-authors were responsible for other specific parts of the work.

Obtaining funding, collecting data, or general oversight of the working group alone does not justify authorship. All those designated as authors must meet the four criteria for authorship, and all those who meet all four criteria must be identified as authors. Contributors who do not meet the four criteria for authorship but who contributed to the study or manuscript must be recognized in the Acknowledgments section, specifying their contribution.

The corresponding author must obtain written permission from all those mentioned in the acknowledgments.

 

When submitting an article, authors must attach: 1) Cover letter, written and signed by the corresponding author, which must explain why the manuscript is of interest to ARP and must be published, which must state that the article is original, that it was only submitted to this journal and which has not been previously published and which complies with the instructions to authors; that the work complies with ethical and legal principles (complyed with the recommendations of the World Medical Association Declaration of Helsinki, was evaluated and approved by an ethics committee, if original study); and what are the sources of financing.

2) Declaration of authorial responsibility (model available), written and signed individually by each of the authors of the work, and in which each one must declare that they meet the authorship criteria and specify their contribution to the work; that is in accordance with the content of the article; whether there are conflicts of interest and what they are; and the assignment of copyright and authorization for the publication of the work. Although editors and reviewers make efforts to ensure the technical and scientific quality of manuscripts, the final responsibility for the content (namely the rigor and precision of the observations, as well as the opinions expressed) lies solely with the authors, to whom the intellectual property of articles.

3) Declaration of Conflicts of Interest. To do this, you must download the document “ICMJE Form for Disclosure of Potential Conflicts of Interest” available at: http://www.icmje.org/conflicts-of-interest/

 

Technical Sheet

Quarterly publication

Editing and Ownership: Sociedade Portuguesa de Radiologia e Medicina Nuclear (SPRMN)

Writing and Administration: SPRMN

Ave. Elias Garcia, 123 - 7ºDto.

1050-098 Lisbon - Portugal

Tel.: 217 970 530 / Fax: 217 955 012

Email: sprmn@sapo.pt

Website: www.sprmn.pt

 

Language

Articles can be submitted in Portuguese or English (English translation services may be provided for articles submitted only in Portuguese).

Titles, abstracts and keywords must always be presented in both languages.

 

Authorizations

Before submitting a manuscript to ARP, authors must have the following documents on hand that may be requested by the editorial board:

- Informed consent from each participant, if applicable;

- Informed consent for each individual present in photographs, even after attempts to hide their identity;

- Authorization to reproduce/use previously published material, to reproduce previously published illustrations;

- Declaration of approval from the ethics committees of the institutions involved, if applicable.

 

Final Note

For a more complete explanation on this subject, it is advisable to read Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations), available at http://www.ICMJE.org.

 

Copyright

Authors retain copyright without restrictions. Acta Radiológica Portuguesa holds the right of first publication, which must be cited in subsequent uses.

 

Self-Archiving Policy (Sherpa/Romeo)

Acta Radiológica Portuguesa allows authors to deposit their articles in institutional repositories, provided that after publication, the original source of the publication in the journal is cited, with a link to the publication and its respective DOI. These conditions can be found at: https://v2.sherpa.ac.uk/id/publication/40037

 

Open Access Policy

This journal offers immediate free access to its content, without payment of processing costs, following the principle that making scientific knowledge freely available to the public provides greater global democratization of knowledge.

Acta Radiológica Portuguesa is licensed under a Creative Commons License - Attribution Non-Commercial (CC BY NC), allowing you to access, download, copy, distribute, print, search, or link articles in full, or use them for any other purpose legal, without seeking prior permission from the publisher or author, for non-commercial purposes. This is in line with the Budapest Open Access Initiative (BOAI) definition of open access.

 

Digital Preservation Policy

This journal is preserved digitally through the Public Knowledge Project (PKP PN) service.